Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

The Lancet Oncology

Volumn 12, Issue 6, 2011, Pages 575-582

  Van Gijn, Willem ^a   Marijnen, Corrie AM ^a   Nagtegaal, Iris D ^b   Kranenbarg, Elma Meershoek Klein ^a   Putter, Hein ^a   Wiggers, Theo ^c   Rutten, Harm JT ^d   Påhlman, Lars ^e   Glimelius, Bengt ^e   Van de Velde, Cornelis JH ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RISK ASSESSMENT; SURVIVAL TIME; TOTAL MESORECTAL EXCISION;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECTAL NEOPLASMS; RECTUM;

EID: 79957502537     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70097-3     Document Type: Article

References (35)

1. MacFarlane JK, Ryall RDH, Heald RJ Mesorectal excision for rectal cancer. Lancet 1993, 341:457-460.
2. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997, 336:980-987. Anon.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646. for the Dutch Colorectal Cancer Group.
4. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007, 246:693-701. for the Dutch Colorectal Cancer Group.
5. Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005, 23:1847-1858.
6. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol 2005, 23:6199-6206.
7. Birgisson H, Påhlman L, Gunnarsson U, Glimelius B Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 2005, 23:6126-6131.
8. Pollack J, Holm T, Cedermark B, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 2006, 93:1519-1525.
9. Bruheim K, Guren MG, Skovlund E, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010, 76:1005-1011.
10. Birgisson H, Påhlman L, Gunnarsson U, Glimelius B Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008, 95:206-213.
11. Dahlberg M, Glimelius B, Graf W, Påhlman L Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 1998, 41:543-549.
12. Kapiteijn E, Kranenbarg EK, Steup WH, et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg 1999, 165:410-420.
13. Quirke P, Dixon MF, Durdey P, Williams NS Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986, 328:996-999.
14. Nagtegaal ID, Kranenbarg EK, Hermans J, van de Velde CJ, van Krieken JH Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers. J Clin Oncol 2000, 18:1771-1779.
15. Grambsch PM, Therneau TM Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994, 81:515-526.
16. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005, 23:5644-5650.
17. Marijnen CA, Nagtegaal ID, Kapiteijn E, et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003, 55:1311-1320. Cooperative Investigators of the Dutch Colorectal Group.
18. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373:811-820.
19. Beets-Tan RG, Lettinga T, Beets GL Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcome. Eur J Surg Oncol 2005, 31:681-688.
20. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007, 94:232-238.
21. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007, 243:132-139. Mercury Study Group.
22. Dutch Surgical Colorectal Audit: Report 2009 2009, Dutch Surgical Colorectal Audit, Amsterdam, (accessed May 12, 2011). http://www.dsca.nl/images/documenten/jaarrapportage%20DSCA%202009.pdf.
23. Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer 2006, 94:351-357.
24. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72:15-24.
25. Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010, 97:580-587.
26. Ngan S, Fisher R, Goldstein D, et al. A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: an intergroup trial (TROG, AGITG, CSSANZ, RACS). Proc Soc Am Clin Oncol 2010, 28(15 suppl). Abstr 3509.
27. Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011, 253:711-719.
28. Bernstein TE, Endreseth BH, Romundstad P, Wibe A Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 2009, 96:1348-1357. Norwegian Colorectal Cancer Group.
29. Lambregts DM, Beets GL, Maas M, et al. Accuracy of Gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 2011, 253:539-545.
30. Koh DM, George C, Temple L, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol 2010, 194:W505-W513.
31. de Heer P, de Bruin EC, Klein-Kranenbarg E, et al. Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res 2007, 13:5810-5815.
32. He Y, Van't Veer LJ, Mikolajewska-Hanclich I, et al. PIK3CA mutations predict local recurrences in rectal cancer patients. Clin Cancer Res 2009, 15:6956-6962.
33. Påhlman L, Glimelius B Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990, 211:187-195.
34. Cedermark B, Johansson H, Rutqvist LE, Wilking N The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995, 75:2269-2275.
35. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001, 92:896-902. Stockholm Colorectal Cancer Group.